Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hyperparathyroidism, Primary | 3 | 2024 | 164 | 1.390 |
Why?
|
| Four-Dimensional Computed Tomography | 4 | 2022 | 141 | 1.310 |
Why?
|
| Parathyroidectomy | 4 | 2021 | 244 | 1.100 |
Why?
|
| Parathyroid Neoplasms | 2 | 2022 | 244 | 0.810 |
Why?
|
| Tomography, X-Ray Computed | 20 | 2024 | 20776 | 0.710 |
Why?
|
| Parathyroid Diseases | 1 | 2020 | 46 | 0.700 |
Why?
|
| Hyperparathyroidism | 3 | 2021 | 339 | 0.580 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 2 | 2017 | 209 | 0.570 |
Why?
|
| Salivary Glands | 1 | 2018 | 231 | 0.560 |
Why?
|
| Head and Neck Neoplasms | 6 | 2023 | 2931 | 0.530 |
Why?
|
| Mouth Diseases | 1 | 2018 | 239 | 0.530 |
Why?
|
| Mouth | 1 | 2018 | 383 | 0.520 |
Why?
|
| Preoperative Care | 3 | 2018 | 2258 | 0.460 |
Why?
|
| Ear Canal | 1 | 2015 | 149 | 0.450 |
Why?
|
| Magnetic Resonance Imaging | 13 | 2022 | 36854 | 0.440 |
Why?
|
| Otologic Surgical Procedures | 1 | 2015 | 150 | 0.430 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2018 | 1141 | 0.430 |
Why?
|
| Skull Base | 1 | 2016 | 294 | 0.420 |
Why?
|
| Information Dissemination | 1 | 2020 | 1141 | 0.400 |
Why?
|
| Skull Base Neoplasms | 1 | 2016 | 281 | 0.400 |
Why?
|
| Spinal Diseases | 1 | 2017 | 563 | 0.400 |
Why?
|
| Adenoma | 1 | 2022 | 2163 | 0.370 |
Why?
|
| Lymph Nodes | 4 | 2023 | 3473 | 0.350 |
Why?
|
| Radiology | 2 | 2021 | 2104 | 0.340 |
Why?
|
| Nephrogenic Fibrosing Dermopathy | 1 | 2009 | 42 | 0.340 |
Why?
|
| Trochlear Nerve | 2 | 2021 | 26 | 0.340 |
Why?
|
| Meglumine | 1 | 2009 | 144 | 0.330 |
Why?
|
| Parathyroid Glands | 2 | 2022 | 522 | 0.300 |
Why?
|
| Neck | 5 | 2022 | 736 | 0.300 |
Why?
|
| Brain Diseases | 1 | 2017 | 1558 | 0.300 |
Why?
|
| Carcinoma, Squamous Cell | 3 | 2017 | 4064 | 0.280 |
Why?
|
| Oropharyngeal Neoplasms | 2 | 2023 | 493 | 0.280 |
Why?
|
| Students, Medical | 1 | 2020 | 1964 | 0.280 |
Why?
|
| Organometallic Compounds | 1 | 2009 | 648 | 0.260 |
Why?
|
| Ultrasonography | 2 | 2018 | 6002 | 0.260 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2013 | 1006 | 0.250 |
Why?
|
| Renal Insufficiency | 1 | 2009 | 812 | 0.220 |
Why?
|
| Internship and Residency | 2 | 2021 | 5956 | 0.220 |
Why?
|
| Cerebral Angiography | 4 | 2013 | 1272 | 0.220 |
Why?
|
| Dyskinesias | 1 | 2023 | 79 | 0.210 |
Why?
|
| Diagnostic Imaging | 1 | 2017 | 3538 | 0.210 |
Why?
|
| Osteitis Fibrosa Cystica | 1 | 2021 | 11 | 0.200 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 2 | 2013 | 101 | 0.190 |
Why?
|
| Confusion | 1 | 2023 | 278 | 0.190 |
Why?
|
| Papillomavirus Infections | 2 | 2023 | 1640 | 0.180 |
Why?
|
| Cranial Nerve Neoplasms | 1 | 2021 | 134 | 0.180 |
Why?
|
| Amyloidogenic Proteins | 1 | 2021 | 154 | 0.170 |
Why?
|
| Anemia, Aplastic | 1 | 2021 | 231 | 0.160 |
Why?
|
| Emergencies | 3 | 2022 | 1221 | 0.160 |
Why?
|
| Salivary Gland Diseases | 1 | 2018 | 37 | 0.160 |
Why?
|
| Hypercalcemia | 1 | 2021 | 424 | 0.160 |
Why?
|
| Face | 2 | 2021 | 1031 | 0.140 |
Why?
|
| Neuroradiography | 1 | 2017 | 71 | 0.140 |
Why?
|
| Parotid Gland | 1 | 2018 | 178 | 0.140 |
Why?
|
| Diagnosis, Differential | 8 | 2021 | 13021 | 0.140 |
Why?
|
| Optic Nerve Neoplasms | 1 | 2016 | 45 | 0.130 |
Why?
|
| Contrast Media | 5 | 2020 | 5334 | 0.130 |
Why?
|
| Exanthema | 1 | 2021 | 503 | 0.130 |
Why?
|
| Neurilemmoma | 1 | 2021 | 524 | 0.130 |
Why?
|
| Manikins | 1 | 2017 | 254 | 0.130 |
Why?
|
| Burkitt Lymphoma | 1 | 2018 | 338 | 0.130 |
Why?
|
| Humans | 42 | 2024 | 768970 | 0.120 |
Why?
|
| Head | 2 | 2021 | 927 | 0.120 |
Why?
|
| Neck Dissection | 1 | 2016 | 201 | 0.120 |
Why?
|
| Syphilis | 1 | 2018 | 243 | 0.120 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 172 | 0.120 |
Why?
|
| Scalp | 2 | 2021 | 391 | 0.120 |
Why?
|
| Practice Guidelines as Topic | 2 | 2024 | 7460 | 0.120 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2017 | 1232 | 0.120 |
Why?
|
| Labyrinth Diseases | 1 | 2015 | 151 | 0.110 |
Why?
|
| Temporal Bone | 2 | 2015 | 683 | 0.110 |
Why?
|
| Vision Disorders | 1 | 2021 | 1093 | 0.110 |
Why?
|
| Professional Competence | 1 | 2006 | 430 | 0.110 |
Why?
|
| Semicircular Canals | 1 | 2015 | 203 | 0.110 |
Why?
|
| Ear Diseases | 1 | 2015 | 181 | 0.110 |
Why?
|
| Ear, Middle | 1 | 2015 | 341 | 0.100 |
Why?
|
| Lymphatic Metastasis | 2 | 2017 | 2916 | 0.100 |
Why?
|
| Hematoma, Subdural | 1 | 2013 | 128 | 0.100 |
Why?
|
| Carcinoma | 1 | 2023 | 2340 | 0.090 |
Why?
|
| Cerebral Hemorrhage | 2 | 2013 | 2660 | 0.090 |
Why?
|
| Thyroidectomy | 1 | 2016 | 914 | 0.090 |
Why?
|
| Bone Marrow | 1 | 2021 | 2936 | 0.090 |
Why?
|
| Myosins | 2 | 2002 | 408 | 0.090 |
Why?
|
| Spine | 1 | 2017 | 1141 | 0.090 |
Why?
|
| Hospital Mortality | 3 | 2013 | 5369 | 0.080 |
Why?
|
| Thyroid Gland | 1 | 2016 | 1171 | 0.080 |
Why?
|
| Head Injuries, Closed | 1 | 2010 | 133 | 0.080 |
Why?
|
| Sinus Thrombosis, Intracranial | 1 | 2010 | 110 | 0.080 |
Why?
|
| Phlebography | 1 | 2010 | 326 | 0.080 |
Why?
|
| Skull Fractures | 1 | 2010 | 203 | 0.080 |
Why?
|
| Male | 22 | 2021 | 365203 | 0.080 |
Why?
|
| Aged, 80 and over | 11 | 2017 | 59739 | 0.080 |
Why?
|
| Emergency Medicine | 1 | 2017 | 1223 | 0.080 |
Why?
|
| Neck Injuries | 1 | 2009 | 162 | 0.070 |
Why?
|
| Trauma Severity Indices | 1 | 2009 | 479 | 0.070 |
Why?
|
| Middle Aged | 19 | 2021 | 223737 | 0.070 |
Why?
|
| Neurosurgical Procedures | 2 | 2012 | 2110 | 0.070 |
Why?
|
| Meningioma | 1 | 2016 | 1226 | 0.070 |
Why?
|
| Retrospective Studies | 12 | 2023 | 81903 | 0.070 |
Why?
|
| Biopsy | 4 | 2021 | 6805 | 0.070 |
Why?
|
| Meningeal Neoplasms | 1 | 2016 | 1258 | 0.070 |
Why?
|
| Young Adult | 7 | 2021 | 60131 | 0.070 |
Why?
|
| Female | 20 | 2023 | 397515 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2023 | 11262 | 0.070 |
Why?
|
| Thyroid Nodule | 1 | 2013 | 767 | 0.070 |
Why?
|
| Health Personnel | 2 | 2017 | 3383 | 0.070 |
Why?
|
| Proteins | 1 | 2021 | 6011 | 0.060 |
Why?
|
| Aged | 14 | 2023 | 171786 | 0.060 |
Why?
|
| Craniocerebral Trauma | 1 | 2009 | 495 | 0.060 |
Why?
|
| Liver | 1 | 2021 | 7578 | 0.060 |
Why?
|
| Heart Transplantation | 3 | 2002 | 3301 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2014 | 1665 | 0.060 |
Why?
|
| Adult | 13 | 2017 | 223851 | 0.050 |
Why?
|
| Thyroid Neoplasms | 1 | 2016 | 2360 | 0.050 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2009 | 807 | 0.050 |
Why?
|
| Eye Pain | 1 | 2022 | 46 | 0.050 |
Why?
|
| Cardiac Myosins | 1 | 2002 | 128 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 9080 | 0.050 |
Why?
|
| Jaw | 1 | 2021 | 95 | 0.050 |
Why?
|
| Bone Marrow Examination | 1 | 2021 | 154 | 0.050 |
Why?
|
| Cytochromes | 1 | 2021 | 18 | 0.050 |
Why?
|
| Facial Pain | 1 | 2022 | 122 | 0.050 |
Why?
|
| Brain | 3 | 2017 | 27453 | 0.050 |
Why?
|
| Brain Mapping | 1 | 2006 | 6739 | 0.050 |
Why?
|
| Sickle Cell Trait | 1 | 2021 | 86 | 0.050 |
Why?
|
| Purpura | 1 | 2021 | 117 | 0.050 |
Why?
|
| Epistaxis | 1 | 2021 | 117 | 0.050 |
Why?
|
| Oropharynx | 1 | 2021 | 139 | 0.050 |
Why?
|
| Licensure | 1 | 2021 | 127 | 0.040 |
Why?
|
| Hydrogen Bonding | 1 | 2021 | 290 | 0.040 |
Why?
|
| Graft Rejection | 3 | 2002 | 4492 | 0.040 |
Why?
|
| Adolescent | 8 | 2021 | 89244 | 0.040 |
Why?
|
| HIV-1 | 1 | 2018 | 6962 | 0.040 |
Why?
|
| Electron Transport | 1 | 2021 | 211 | 0.040 |
Why?
|
| Electric Conductivity | 1 | 2021 | 408 | 0.040 |
Why?
|
| Telemedicine | 1 | 2017 | 3110 | 0.040 |
Why?
|
| Orthognathic Surgical Procedures | 1 | 2021 | 120 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2021 | 222 | 0.040 |
Why?
|
| Blepharoptosis | 1 | 2021 | 145 | 0.040 |
Why?
|
| Electrons | 1 | 2021 | 264 | 0.040 |
Why?
|
| Liver Function Tests | 1 | 2021 | 526 | 0.040 |
Why?
|
| Myocardium | 2 | 2002 | 4790 | 0.040 |
Why?
|
| Comorbidity | 2 | 2013 | 10592 | 0.040 |
Why?
|
| Observer Variation | 2 | 2013 | 2623 | 0.040 |
Why?
|
| Uncertainty | 1 | 2023 | 769 | 0.040 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2021 | 427 | 0.040 |
Why?
|
| Intracranial Hemorrhages | 1 | 2023 | 811 | 0.040 |
Why?
|
| Glioblastoma | 1 | 2012 | 3525 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2018 | 411 | 0.030 |
Why?
|
| Massachusetts | 1 | 2009 | 8894 | 0.030 |
Why?
|
| Tyrosine | 1 | 2021 | 1427 | 0.030 |
Why?
|
| Reproducibility of Results | 3 | 2023 | 20245 | 0.030 |
Why?
|
| Prevalence | 2 | 2010 | 15879 | 0.030 |
Why?
|
| Protons | 1 | 2021 | 1113 | 0.030 |
Why?
|
| Geniculate Ganglion | 1 | 2015 | 9 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2013 | 15951 | 0.030 |
Why?
|
| Brain Neoplasms | 2 | 2012 | 9213 | 0.030 |
Why?
|
| Schools, Medical | 1 | 2021 | 883 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2021 | 2226 | 0.030 |
Why?
|
| Educational Measurement | 1 | 2021 | 1260 | 0.030 |
Why?
|
| Fever | 1 | 2021 | 1619 | 0.030 |
Why?
|
| Stem Cell Transplantation | 1 | 2021 | 1602 | 0.030 |
Why?
|
| Skin Neoplasms | 1 | 2012 | 5864 | 0.030 |
Why?
|
| Algorithms | 2 | 2023 | 14201 | 0.020 |
Why?
|
| Graft Survival | 1 | 2002 | 3888 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 2018 | 1780 | 0.020 |
Why?
|
| HIV Infections | 1 | 2018 | 17591 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2012 | 564 | 0.020 |
Why?
|
| Sensitivity and Specificity | 2 | 2017 | 14752 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2006 | 2267 | 0.020 |
Why?
|
| Demography | 1 | 2014 | 1642 | 0.020 |
Why?
|
| Glasgow Coma Scale | 1 | 2011 | 579 | 0.020 |
Why?
|
| Transplantation, Homologous | 3 | 2002 | 4835 | 0.020 |
Why?
|
| Brain Stem | 1 | 2014 | 862 | 0.020 |
Why?
|
| Jugular Veins | 1 | 2010 | 211 | 0.020 |
Why?
|
| Hematoma | 1 | 2013 | 768 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2009 | 24333 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 2002 | 10276 | 0.020 |
Why?
|
| Craniotomy | 1 | 2012 | 747 | 0.020 |
Why?
|
| Acute Disease | 2 | 2013 | 7245 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2012 | 1836 | 0.020 |
Why?
|
| Logistic Models | 2 | 2013 | 13318 | 0.020 |
Why?
|
| Causality | 1 | 2013 | 1256 | 0.020 |
Why?
|
| Risk Factors | 2 | 2013 | 74976 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2013 | 15471 | 0.020 |
Why?
|
| Area Under Curve | 1 | 2009 | 1645 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2018 | 2294 | 0.020 |
Why?
|
| Infant | 3 | 2014 | 36556 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 8559 | 0.010 |
Why?
|
| Child, Preschool | 3 | 2014 | 42683 | 0.010 |
Why?
|
| Models, Biological | 1 | 2021 | 9499 | 0.010 |
Why?
|
| Prognosis | 2 | 2013 | 30046 | 0.010 |
Why?
|
| Autoimmunity | 2 | 2002 | 1360 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 3438 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 2 | 2002 | 6232 | 0.010 |
Why?
|
| Child | 4 | 2014 | 80960 | 0.010 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2012 | 2059 | 0.010 |
Why?
|
| Mice, Inbred A | 1 | 2001 | 245 | 0.010 |
Why?
|
| Interleukin-5 | 1 | 2002 | 267 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2013 | 9684 | 0.010 |
Why?
|
| CD40 Ligand | 1 | 2002 | 528 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2831 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2013 | 12095 | 0.010 |
Why?
|
| Boston | 1 | 2013 | 9377 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12873 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 11116 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 1157 | 0.010 |
Why?
|
| Antibody Formation | 1 | 2002 | 1393 | 0.010 |
Why?
|
| Organ Specificity | 1 | 2002 | 1970 | 0.010 |
Why?
|
| Th1 Cells | 1 | 2002 | 1042 | 0.010 |
Why?
|
| Chronic Disease | 2 | 2002 | 9384 | 0.010 |
Why?
|
| Th2 Cells | 1 | 2002 | 1079 | 0.010 |
Why?
|
| Epitopes | 1 | 2002 | 2529 | 0.010 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2002 | 1363 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4478 | 0.010 |
Why?
|
| Incidence | 1 | 2013 | 21547 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2006 | 15889 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 2 | 2002 | 22379 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2012 | 9442 | 0.010 |
Why?
|
| Interferon-gamma | 1 | 2001 | 3163 | 0.010 |
Why?
|
| United States | 1 | 2021 | 73186 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2002 | 5505 | 0.010 |
Why?
|
| Erythema Multiforme | 1 | 1951 | 31 | 0.010 |
Why?
|
| Mice | 3 | 2002 | 82072 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2013 | 54962 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2011 | 41808 | 0.000 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 1951 | 232 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2013 | 65480 | 0.000 |
Why?
|
| Animals | 3 | 2002 | 169335 | 0.000 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 9264 | 0.000 |
Why?
|
Concepts
(230)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(68)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_